Aethlon Medical, Inc. Healthcare - Medical Equipment SWOT Report

Publication Date	May 2008
Publisher	Global Markets Direct
Product Type	Report
Pages	24
ISBN Number	not applicable
Product Code	GMD04608

Price

£67.00
approximately: $125 | €85

PDF

Order above formats by FAX

Summary

Aethlon Medical, Inc. Healthcare - Medical Equipment SWOT Report is a comprehensive report of the company including both quantitative and qualitative research. The report examines the company's business structure and operations, history and products. The report provides strategic insight on the company in the form of a SWOT analysis. This studies the major internal factors which will affect the company's performance e.g. size, strength, cost, revenues and strategy as well as external factors e.g. competitive positioning and industry trends. There is a forward-looking discussion of the opportunities the company can exploit and the threats facing it.

Report Coverage

Critical appraisal of the company's positioning using SWOT analysis.
Company information, including business descriptions, company history, product lines, key competitors and key employee biographies.
Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
Key mergers and acquisitions, partnerships, private equity investments and IPOs.

Reasons to buy

Support business/sales activities by understanding customers' businesses better.
Identify prospective partners and suppliers.
Capitalize on your competitors weaknesses and target the market opportunities available to them.

Content

1 Table of Contents
1 Table of Contents
- 1.1 List of Tables
2 Company Snapshot
- 2.1 Key Information
- 2.2 Company Overview
- 2.3 Financial Performance
3 Business Description
- 3.1 Business Overview
- 3.2 Major Products and Services
  - 3.2.1 Overview
4 History
5 SWOT Analysis
- 5.1 Overview
- 5.2 Aethlon Medical, Inc. Strengths
  - 5.2.1 The Hemopurifier Platform Technology
  - 5.2.2 Strong Research and Development Capability
- 5.3 Aethlon Medical, Inc. Weaknesses
  - 5.3.1 Limited Manufacturing Experience
  - 5.3.2 Operating Losses
  - 5.3.3 Working Capital Requirement
- 5.4 Aethlon Medical, Inc. Opportunities
  - 5.4.1 FDA Submission for Hemopurifier
  - 5.4.2 The Hemopurifier Technology in Cancer Care
  - 5.4.3 Expanding Product Pipeline
  - 5.4.4 Collaborations
- 5.5 Aethlon Medical, Inc. Threats
  - 5.5.1 Product Liability Claims
  - 5.5.2 Intense Competition
  - 5.5.3 Technological Developments
6 Competitors
7 Key Employees
8 Key Employee Biographies
9 Company Statement
10 Locations And Subsidiaries
- 10.1 Head Office
11 Recent Developments
- 11.1 Strategy and Business Planning
  - 11.1.1 Feb 28, 2007: Aethlon Declares Lassa Virus Research Study
  - 11.1.2 Jan 26, 2007: Aethlon Updates On EHF Research Study
  - 11.1.3 Dec 05, 2006: Aethlon Announces Collaboration With NIV
  - 11.1.4 Apr 19, 2006: Aethlon Completes Human Safety Study
- 11.2 Product Announcements
  - 11.2.1 Mar 20, 2007: Aethlon Files Patent for Cancer Treatment
  - 11.2.2 Mar 06, 2007: Aethlon Declares FDA Submission
  - 11.2.3 Nov 28, 2006: Aethlon To Submit BioShield's Regulatory Plan
  - 11.2.4 Nov 13, 2006: Aethlon Acquires Patent Rights For Strategic Cancer Therapy
- 11.3 Financial Announcements
  - 11.3.1 Mar 22, 2007: Aethlon Completes Common Stock Purchase Agreement
- 11.4 Other Significant Developments
  - 11.4.1 Mar 19, 2008: Aethlon Appoints Director, Investor Relations
  - 11.4.2 Jan 09, 2008: Aethlon Appoints SVP, Finance
  - 11.4.3 Oct 17, 2006: Aethlon Appoints New Member To Science Advisory Board
  - 11.4.4 Jul 18, 2006: Aethlon Appoints President
12 Appendix
- 12.1 Methodology
- 12.2 About Global Markets Direct
- 12.3 Contact Us
- 12.4 Disclaimer
List of Tables
- Table 1: Aethlon Medical, Inc.,Key Facts
- Table 2: Aethlon Medical, Inc., SWOT Analysis
- Table 3: Aethlon Medical, Inc., Key Employees,